Table of Contents
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-aways
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Narcolepsy Therapeutics Market Insights
3.1. Narcolepsy Therapeutics– Industry snapshot
3.2. Narcolepsy Therapeutics- Ecosystem analysis
3.3. Narcolepsy Therapeutics Market dynamics
3.3.1. Narcolepsy Therapeutics– Market Forces
3.3.1.1. Narcolepsy Therapeutics Market driver analysis
3.3.1.2. Narcolepsy Therapeutics Market restraint/challenges analysis
3.3.1.3. Narcolepsy Therapeutics Market opportunity analysis
3.3.2. Industry analysis - Porter's five force
3.3.2.1. Bargaining power of supplier
3.3.2.2. Bargaining power of buyer
3.3.2.3. Threat of substitute
3.3.2.4. Threat of new entrant
3.3.2.5. Degree of competition
3.3.3. Narcolepsy Therapeutics Market PEST analysis, 2017
3.3.4. Narcolepsy Therapeutics Industry trends
3.3.5. Competitive Ranking Analysis
4. Narcolepsy Therapeutics Market Size and Forecast by Product
4.1. Key findings
4.2. Sodium Oxybate
4.2.1. Global market estimates and forecasts, 2017 – 2025
4.3. Central Nervous System Stimulants
4.3.1. Global market estimates and forecasts, 2017 – 2025
4.4. Selective Serotonin Reuptake Inhibitor
4.4.1. Global market estimates and forecasts, 2017 – 2025
4.5. Tricyclic Antidepressants
4.5.1. Global market estimates and forecasts, 2017 – 2025
5. Narcolepsy Therapeutics Market Size and Forecast by Type
5.1. Key findings
5.2. Cataplexy
5.2.1. Global market estimates and forecasts, 2017 - 2025
5.3. Narcolepsy without Cataplexy
5.3.1. Global market estimates and forecasts, 2017 - 2025
5.4. Secondary Narcolepsy
5.4.1. Global market estimates and forecasts, 2017 – 2025
6. Narcolepsy Therapeutics Market Size and Forecast by Regions
6.1. Key findings
6.2. North America
6.2.1. Narcolepsy Therapeutics Market by Product, 2017 - 2025
6.2.2. Narcolepsy Therapeutics Market by Type, 2017 - 2025
6.2.3. U.S.
6.2.3.1. Narcolepsy Therapeutics Market by Product, 2017 - 2025
6.2.3.2. Narcolepsy Therapeutics Market by Type, 2017 - 2025
6.2.4. Canada
6.2.4.1. Narcolepsy Therapeutics Market by Product, 2017 - 2025
6.2.4.2. Narcolepsy Therapeutics Market by Type, 2017 - 2025
6.3. Europe
6.3.1. Narcolepsy Therapeutics Market by Product, 2017 - 2025
6.3.2. Narcolepsy Therapeutics Market by Type, 2017 - 2025
6.3.3. Germany
6.3.3.1. Narcolepsy Therapeutics Market by Product, 2017 - 2025
6.3.3.2. Narcolepsy Therapeutics Market by Type, 2017 - 2025
6.3.4. UK
6.3.4.1. Narcolepsy Therapeutics Market by Product, 2017 - 2025
6.3.4.2. Narcolepsy Therapeutics Market by Type, 2017 - 2025
6.3.5. France
6.3.5.1. Narcolepsy Therapeutics Market by Product, 2017 - 2025
6.3.5.2. Narcolepsy Therapeutics Market by Type, 2017 - 2025
6.3.6. Italy
6.3.6.1. Narcolepsy Therapeutics Market by Product, 2017 - 2025
6.3.6.2. Narcolepsy Therapeutics Market by Type, 2017 - 2025
6.4. Asia Pacific
6.4.1. Narcolepsy Therapeutics Market by Product, 2017 - 2025
6.4.2. Narcolepsy Therapeutics Market by Type, 2017 - 2025
6.4.3. China
6.4.3.1. Narcolepsy Therapeutics Market by Product, 2017 - 2025
6.4.3.2. Narcolepsy Therapeutics Market by Type, 2017 - 2025
6.4.4. India
6.4.4.1. Narcolepsy Therapeutics Market by Product, 2017 - 2025
6.4.4.2. Narcolepsy Therapeutics Market by Type, 2017 - 2025
6.4.5. Japan
6.4.5.1. Narcolepsy Therapeutics Market by Product, 2017 - 2025
6.4.5.2. Narcolepsy Therapeutics Market by Type, 2017 - 2025
6.4.6. Australia
6.4.6.1. Narcolepsy Therapeutics Market by Product, 2017 - 2025
6.4.6.2. Narcolepsy Therapeutics Market by Type, 2017 - 2025
6.5. Latin America
6.5.1. Narcolepsy Therapeutics Market by Product, 2017 - 2025
6.5.2. Narcolepsy Therapeutics Market by Type, 2017 - 2025
6.5.3. Brazil
6.5.3.1. Narcolepsy Therapeutics Market by Product, 2017 - 2025
6.5.3.2. Narcolepsy Therapeutics Market by Type, 2017 - 2025
6.5.4. Mexico
6.5.4.1. Narcolepsy Therapeutics Market by Product, 2017 - 2025
6.5.4.2. Narcolepsy Therapeutics Market by Type, 2017 - 2025
6.6. Middle East & Africa
6.6.1. Narcolepsy Therapeutics Market by Product, 2017 - 2025
6.6.2. Narcolepsy Therapeutics Market by Type, 2017 - 2025
7. Company Profiles
7.1. Addrenex Pharmaceuticals, Inc.
7.1.1. Overview
7.1.2. Financials
7.1.3. Product Benchmarking
7.1.4. Recent Developments
7.2. Arena Pharmaceuticals, Inc.
7.2.1. Overview
7.2.2. Financials
7.2.3. Product Benchmarking
7.2.4. Recent Developments
7.3. BIOPROJET, Cephalon, Inc.
7.3.1. Overview
7.3.2. Financials
7.3.3. Product Benchmarking
7.3.4. Recent Developments
7.4. Evotec AG
7.4.1. Overview
7.4.2. Financials
7.4.3. Product Benchmarking
7.4.4. Recent Developments
7.5. Graymark Healthcare, Inc.
7.5.1. Overview
7.5.2. Financials
7.5.3. Product Benchmarking
7.5.4. Recent Developments
7.6. Hypnion, Inc.
7.6.1. Overview
7.6.2. Financials
7.6.3. Product Benchmarking
7.6.4. Recent Developments
7.7. Jazz Pharmaceuticals, Inc.
7.7.1. Overview
7.7.2. Financials
7.7.3. Product Benchmarking
7.7.4. Recent Developments
7.8. Ligand Pharmaceuticals, Inc.
7.8.1. Overview
7.8.2. Financials
7.8.3. Product Benchmarking
7.8.4. Recent Developments
7.9. Teva Pharmaceutical Industries Ltd.
7.9.1. Overview
7.9.2. Financials
7.9.3. Product Benchmarking
7.9.4. Recent Developments